A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes.
about
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity.Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer.Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor siteRecent progress in adjuvant discovery for peptide-based subunit vaccinesImproving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigenSequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer.Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agentsT-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasiaCytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomasEffects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice.Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variationProduction and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein.BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses.Design and development of synthetic peptide vaccines: past, present and future.Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenesPeptide-based vaccines for cancer: realizing their potential.Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L.Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products.Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism.Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines.Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term.A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant.Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences.Microwave-assisted synthesis of difficult sequence-containing peptides using the isopeptide method.Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model.A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines
P2860
Q27469893-A38F592A-3DA0-421D-A496-1933DE93D449Q33650663-7C79B601-EB37-4AF6-B9FC-975235987C17Q33714644-8494347D-C4E9-4CD1-A8B9-8A4805A290DBQ33800432-B18C309E-7909-4857-9E40-D1340EC075E6Q33846428-397B63FC-8BB4-4F6D-8EA9-8408B2E9CC55Q34033780-B44A0B8D-DB46-431C-9926-41D31B7EF3F7Q34332858-59F97A29-3616-4A9A-8CDA-5EEBAC8BD739Q34822738-EDFEBD98-28A3-4FAE-852E-BE95ECF40E7BQ35102014-EBE125C8-195A-4F9F-9193-67D31F6E16E4Q35226091-CDE21644-091E-4E9E-BD78-8ECC3C395DD3Q35543857-921A9855-A255-4CA0-8FC9-B3525BBEC23FQ35830690-3E354796-98B7-4EC9-A182-4892C5EED4F2Q35946659-FBF56E57-1E70-4E27-8BC9-F194408BA0B7Q36167792-60FD6617-30B3-4C45-BEE3-961657647FD4Q36231126-A48722B9-7A80-451A-B6E4-D71F960F6B37Q36645694-52EEB838-3883-4288-9875-CD10112523BDQ36763266-18E458E3-4225-4D65-9ABC-9A4E7F31A573Q36899093-5D322D8F-203D-4510-B557-6964C0C47B61Q37196059-FE891493-83FC-42F0-A739-1A293F14A76AQ37340462-1F9435F8-FD7E-435A-961C-3977F215825AQ37499652-AF96F3ED-B0B8-4C43-9544-770F0CFDD7D5Q37661001-F18DD48A-8A58-4BBA-BFCB-A22FFD0E668EQ39999888-0F8D148F-EEAF-41E0-897C-FF78587A29C7Q40566671-2CA90A01-693F-4978-820E-C0A9AF2ED01DQ40712474-6ABD252F-51A1-4F27-985F-DF16D8DCBFEEQ40811128-26BABAD7-54D6-433F-8665-C1560AC58877Q41034036-E90A1E43-B3A6-4C18-B55C-05322A497043Q42505471-15C4C41D-58BB-49E3-B87D-32B06CA4547EQ42638946-41135C23-2211-4879-9362-E56DA94A91A3Q44347647-6FB3F417-0AA3-42CB-9646-F886D2027668Q50058150-673618FA-B7D5-4624-AB82-690FE11FF7FAQ54607806-B0743E80-1A10-4545-887F-4E6F4F700816Q57607841-B713FCAE-F7C8-42CD-9AF5-4AFF4558FDBB
P2860
A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A "public" T-helper epitope of ...... uman papillomavirus genotypes.
@en
A "public" T-helper epitope of ...... uman papillomavirus genotypes.
@nl
type
label
A "public" T-helper epitope of ...... uman papillomavirus genotypes.
@en
A "public" T-helper epitope of ...... uman papillomavirus genotypes.
@nl
prefLabel
A "public" T-helper epitope of ...... uman papillomavirus genotypes.
@en
A "public" T-helper epitope of ...... uman papillomavirus genotypes.
@nl
P2093
P2860
P356
P1476
A "public" T-helper epitope of ...... uman papillomavirus genotypes.
@en
P2093
Fernando GJ
Sterling JC
P2860
P304
P356
10.1073/PNAS.88.13.5887
P407
P577
1991-07-01T00:00:00Z